PER 1.25% 7.9¢ percheron therapeutics limited

ATL1102 US Patent - very interesting, page-41

  1. 4,683 Posts.
    lightbulb Created with Sketch. 1086
    Woldanorf,

    Yes they can negotiate the value - BUT they don't yet have PRV...they can apply for it when they submit their marketing application after P2B.

    At the moment they have RPDD status for ATL1102, which is a prerequisite to apply for PRV.

    So, it won't help them now with funding, but RPDD status is useful / valuable for any Big Pharma wanting equity / TO play.

    .
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
7.9¢
Change
-0.001(1.25%)
Mkt cap ! $72.12M
Open High Low Value Volume
8.0¢ 8.2¢ 7.8¢ $35.22K 439.8K

Buyers (Bids)

No. Vol. Price($)
2 23274 7.9¢
 

Sellers (Offers)

Price($) Vol. No.
8.1¢ 17891 1
View Market Depth
Last trade - 12.58pm 17/07/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.